63 related articles for article (PubMed ID: 29517839)
1. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
2. PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.
Zhong J; Yuan C; Liu L; Du Y; Hui Y; Chen Z; Diao C; Yang R; Liu G; Liu X
Aging (Albany NY); 2023 Oct; 15(20):11654-11671. PubMed ID: 37899170
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
Wang Y; Zhang M; Zhang Z; Li B; Huang J; Li J; Geng Z; Zhang X; Song X; Wang L; Zuo L; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1167-1175. PubMed ID: 38162070
[TBL] [Abstract][Full Text] [Related]
4. PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells.
Saiding A; Maimaitiyiming D; Chen M; Yan F; Chen D; Hu X; Shi P
PeerJ; 2023; 11():e16006. PubMed ID: 37953789
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.
Hao H; Chen H; Xie L; Liu H
Ann Med; 2021 Dec; 53(1):1170-1178. PubMed ID: 34259106
[TBL] [Abstract][Full Text] [Related]
6. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.
Liu J; Liu B; Li Y; Mi Z; Tan H; Rong P
Eur J Med Res; 2023 Aug; 28(1):289. PubMed ID: 37596654
[TBL] [Abstract][Full Text] [Related]
7. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
8. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
[TBL] [Abstract][Full Text] [Related]
9. Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
Park S; Rong L; Owczarek TB; Bernardo MD; Shoulson RL; Chua CW; Kim JY; Lankarani A; Chakrapani P; Syed T; McKiernan JM; Solit DB; Shen MM; Al-Ahmadie HA; Abate-Shen C
Cancer Res; 2021 Oct; 81(20):5161-5175. PubMed ID: 34470779
[TBL] [Abstract][Full Text] [Related]
10. Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.
Lin YZ; Liu WH; Wu YP; Cai H; Zheng QS; Wei Y; Xu N; Xue XY
Int J Immunopathol Pharmacol; 2024; 38():3946320241240706. PubMed ID: 38712735
[No Abstract] [Full Text] [Related]
11. LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
Zhang P; Xie X; Li C; Zhang C; Liang P
Cancer Med; 2023 Oct; 12(19):19758-19776. PubMed ID: 37706625
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of protein-L-isoaspartate (D-aspartate)
Yamashita M; Ogasawara M; Kawasaki Y; Niisato M; Saito H; Kasai S; Maesawa C; Maemondo M; Yamauchi K
Oncotarget; 2018 Mar; 9(17):13287-13300. PubMed ID: 29568357
[TBL] [Abstract][Full Text] [Related]
13. Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
Duex JE; Owens C; Chauca-Diaz A; Dancik GM; Vanderlinden LA; Ghosh D; Leivo MZ; Hansel DE; Theodorescu D
Cancer Res; 2017 Sep; 77(18):4858-4867. PubMed ID: 28674079
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase TTK promotes proliferation and migration and mediates epithelial-mesenchymal transition in human bladder cancer cells.
Chen F; Wu P; Hu H; Tian D; Jiang N; Wu C
Int J Clin Exp Pathol; 2018; 11(10):4854-4861. PubMed ID: 31949560
[TBL] [Abstract][Full Text] [Related]
15. Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters.
Zhang QY; Fu MT; Zhang ZF; Feng YZ; Wei M; Zhou JY; Shi R
Int J Clin Exp Pathol; 2017; 10(7):8050-8057. PubMed ID: 31966657
[TBL] [Abstract][Full Text] [Related]
16. Protein-L-isoaspartate O-methyltransferase is required for
D'Alessandro A; Hay A; Dzieciatkowska M; Brown BC; Morrison EJ; Hansen KC; Zimring JC
Haematologica; 2021 Oct; 106(10):2726-2739. PubMed ID: 33054131
[TBL] [Abstract][Full Text] [Related]
17. PIMT/NCOA6IP Deletion in the Mouse Heart Causes Delayed Cardiomyopathy Attributable to Perturbation in Energy Metabolism.
Jia Y; Liu N; Viswakarma N; Sun R; Schipma MJ; Shang M; Thorp EB; Kanwar YS; Thimmapaya B; Reddy JK
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772707
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L; Pirman D; Mahoney CE; Coloma J; Calsina B; Currás-Freixes M; Letón R; Torres-Pérez R; Richter S; Pita G; Herráez B; Cianchetta G; Honrado E; Maestre L; Urioste M; Aller J; García-Uriarte Ó; Gálvez MÁ; Luque RM; Lahera M; Moreno-Rengel C; Eisenhofer G; Montero-Conde C; Rodríguez-Antona C; Llorca Ó; Smolen GA; Robledo M; Cascón A
Am J Hum Genet; 2019 Apr; 104(4):651-664. PubMed ID: 30929736
[TBL] [Abstract][Full Text] [Related]
19. Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.
Ozay EI; Shanthalingam S; Torres JA; Osborne BA; Tew GN; Minter LM
Mol Ther; 2020 Oct; 28(10):2220-2236. PubMed ID: 32592691
[TBL] [Abstract][Full Text] [Related]
20.
Jia G; Yang H; Diao Z; Liu Y; Sun C
Eur J Histochem; 2020 Oct; 64(s2):. PubMed ID: 33334092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
